The Latin America, Middle East and Africa Omega 3 Supplements Market would witness market growth of 10.8% CAGR during the forecast period (2024-2031).
The Brazil market dominated the LAMEA Omega 3 Supplements Market by Country in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $315.3 million by 2031. The Argentina market is showcasing a CAGR of 11.5% during (2024 - 2031). Additionally, The UAE market would register a CAGR of 9.7% during (2024 - 2031).
The applications of omega-3 supplements are vast and multifaceted, reflecting their versatility in addressing a wide array of health needs. The most prominent application lies in dietary supplements, where omega-3s are consumed to meet daily nutritional requirements and support overall health. These supplements are particularly popular for their cardiovascular benefits, as EPA and DHA have been linked to reduced triglyceride levels, lower blood pressure, and a decreased risk of heart disease—a critical concern given that cardiovascular issues remain a leading cause of mortality globally. In the United States, for instance, coronary heart disease accounts for a significant portion of deaths, amplifying the demand for omega-3 supplements as a preventive measure.
Moreover, beyond cardiovascular health, omega-3 supplements are widely applied in cognitive and neurological support. DHA, a key component of brain tissue, is essential for infant brain development and cognitive function in adults. This has led to their incorporation into infant formulas, ensuring that young children receive adequate levels for optimal growth. For aging populations, omega-3s are marketed as a tool to combat cognitive decline, with potential benefits for conditions like dementia and Alzheimer’s disease. As per the WHO, more than 55 million people have dementia worldwide, over 60% of whom live in low-and middle-income countries. Every year, there are nearly 10 million new cases.
Saudi Arabia’s pharmaceutical industry is expected to grow 7.3% from 2020 to 2027, mainly due to the increasing number of drug approvals and new product launches. This growth directly impacts the market, as Omega-3 fatty acids are widely used in pharmaceutical formulations for cardiovascular health, brain function, and inflammation reduction. With rising cases of heart disease and lifestyle-related illnesses in Saudi Arabia, demand for Omega-3 supplements is increasing as a preventive healthcare solution. Additionally, government support for pharmaceutical expansion enhances the availability and acceptance of Omega-3-based drugs and supplements.
Free Valuable Insights: The Worldwide Omega 3 Supplements Market is Projected to reach USD 12.91 Billion by 2031, at a CAGR of 8.6%
Based on Functionality, the market is segmented into Cardiovascular Health, Brain, Nervous System & Mental Health, Eye Diseases, Diabetes, and Other Functionality. Based on End Use, the market is segmented into Adults, Geriatric, Pregnant Women, Children, and Infants. Based on Source, the market is segmented into Fish Oil, Algae Oil, Krill Oil, and Other Source. Based on Distribution Channel, the market is segmented into Supermarkets/ Hypermarkets/Food Stores, Drug Stores & Pharmacies, Online Retailers, Prescribed, and Other Distribution Channel. Based on Form, the market is segmented into Soft Gels, Capsules, Tablets, and Other Form. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
By Functionality
By End Use
By Source
By Distribution Channel
By Form
By Country
Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
Unique Offerings 